[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A1).
TISSUE=Brain;
DOI=10.1093/hmg/3.6.909; PubMed=7951235 [NCBI, ExPASy, EBI, Israel, Japan]
Duclos F.,
Rodius F.,
Wrogemann K.,
Mandel J.-L.,
Koenig M.;
"The Friedreich ataxia region: characterization of two novel genes and reduction of the critical region to 300 kb.";
Hum. Mol. Genet. 3:909-914(1994).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS A1; C1; A2 AND C2), AND ALTERNATIVE PROMOTER USAGE.
TISSUE=Pancreas;
DOI=10.1016/S0167-4781(00)00185-8; PubMed=11018256 [NCBI, ExPASy, EBI, Israel, Japan]
Chlenski A.,
Ketels K.V.,
Korovaitseva G.I.,
Talamonti M.S.,
Oyasu R.,
Scarpelli D.G.;
"Organization and expression of the human zo-2 gene (tjp-2) in normal and neoplastic tissues.";
Biochim. Biophys. Acta 1493:319-324(2000).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A3).
Yan H.H.,
Rong L.,
Qiang S.,
Jian W.,
Peng Z.,
Hua H.,
Hui Z.W.;
"LIM protein KyoT2 interacts with human tight junction protein ZO-2-i3.";
Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ASP-482.
DOI=10.1038/nature02465; PubMed=15164053 [NCBI, ExPASy, EBI, Israel, Japan]
Humphray S.J.,
Oliver K.,
Hunt A.R.,
Plumb R.W.,
Loveland J.E.,
Howe K.L.,
Andrews T.D.,
Searle S.,
Hunt S.E.,
Scott C.E.,
Jones M.C.,
Ainscough R.,
Almeida J.P.,
Ambrose K.D.,
Ashwell R.I.S.,
Babbage A.K.,
Babbage S.,
Bagguley C.L.,
Bailey J.,
Banerjee R.,
Barker D.J.,
Barlow K.F.,
Bates K.,
Beasley H.,
Beasley O.,
Bird C.P.,
Bray-Allen S.,
Brown A.J.,
Brown J.Y.,
Burford D.,
Burrill W.,
Burton J.,
Carder C.,
Carter N.P.,
Chapman J.C.,
Chen Y.,
Clarke G.,
Clark S.Y.,
Clee C.M.,
Clegg S.,
Collier R.E.,
Corby N.,
Crosier M.,
Cummings A.T.,
Davies J.,
Dhami P.,
Dunn M.,
Dutta I.,
Dyer L.W.,
Earthrowl M.E.,
Faulkner L.,
Fleming C.J.,
Frankish A.,
Frankland J.A.,
French L.,
Fricker D.G.,
Garner P.,
Garnett J.,
Ghori J.,
Gilbert J.G.R.,
Glison C.,
Grafham D.V.,
Gribble S.,
Griffiths C.,
Griffiths-Jones S.,
Grocock R.,
Guy J.,
Hall R.E.,
Hammond S.,
Harley J.L.,
Harrison E.S.I.,
Hart E.A.,
Heath P.D.,
Henderson C.D.,
Hopkins B.L.,
Howard P.J.,
Howden P.J.,
Huckle E.,
Johnson C.,
Johnson D.,
Joy A.A.,
Kay M.,
Keenan S.,
Kershaw J.K.,
Kimberley A.M.,
King A.,
Knights A.,
Laird G.K.,
Langford C.,
Lawlor S.,
Leongamornlert D.A.,
Leversha M.,
Lloyd C.,
Lloyd D.M.,
Lovell J.,
Martin S.,
Mashreghi-Mohammadi M.,
Matthews L.,
McLaren S.,
McLay K.E.,
McMurray A.,
Milne S.,
Nickerson T.,
Nisbett J.,
Nordsiek G.,
Pearce A.V.,
Peck A.I.,
Porter K.M.,
Pandian R.,
Pelan S.,
Phillimore B.,
Povey S.,
Ramsey Y.,
Rand V.,
Scharfe M.,
Sehra H.K.,
Shownkeen R.,
Sims S.K.,
Skuce C.D.,
Smith M.,
Steward C.A.,
Swarbreck D.,
Sycamore N.,
Tester J.,
Thorpe A.,
Tracey A.,
Tromans A.,
Thomas D.W.,
Wall M.,
Wallis J.M.,
West A.P.,
Whitehead S.L.,
Willey D.L.,
Williams S.A.,
Wilming L.,
Wray P.W.,
Young L.,
Ashurst J.L.,
Coulson A.,
Blocker H.,
Durbin R.M.,
Sulston J.E.,
Hubbard T.,
Jackson M.J.,
Bentley D.R.,
Beck S.,
Rogers J.,
Dunham I.;
"DNA sequence and analysis of human chromosome 9.";
Nature 429:369-374(2004).
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A1), AND VARIANT ASP-482.
TISSUE=Testis;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[6]
|
NUCLEOTIDE SEQUENCE OF 1-104 (ISOFORMS A1 AND C1).
TISSUE=Pancreas;
DOI=10.1002/(SICI)1097-0215(19990702)82:1<137::AID-IJC23>3.0.CO;2-F; PubMed=10360833 [NCBI, ExPASy, EBI, Israel, Japan]
Chlenski A.,
Ketels K.V.,
Tsao M.-S.,
Talamonti M.S.,
Anderson M.R.,
Oyasu R.,
Scarpelli D.G.;
"Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma.";
Int. J. Cancer 82:137-144(1999).
|
[7]
|
PARTIAL NUCLEOTIDE SEQUENCE (ISOFORMS A1 AND C1), AND ALTERNATIVE PROMOTER USAGE.
TISSUE=Pancreas;
DOI=10.1002/(SICI)1097-0215(19991029)83:3<349::AID-IJC10>3.0.CO;2-C; PubMed=10495427 [NCBI, ExPASy, EBI, Israel, Japan]
Chlenski A.,
Ketels K.V.,
Engeriser J.L.,
Talamonti M.S.,
Tsao M.-S.,
Koutnikova H.,
Oyasu R.,
Scarpelli D.G.;
"Zo-2 gene alternative promoters in normal and neoplastic human pancreatic duct cells.";
Int. J. Cancer 83:349-358(1999).
|
[8]
|
NUCLEOTIDE SEQUENCE OF 1047-1167.
TISSUE=Aortic smooth muscle;
Adams L.D.,
Werny I.,
Schwartz S.M.;
Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
|
[9]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266; SER-296 AND SER-1159, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1073/pnas.0404720101; PubMed=15302935 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A.,
Jedrychowski M.,
Schwartz D.,
Elias J.E.,
Villen J.,
Li J.,
Cohn M.A.,
Cantley L.C.,
Gygi S.P.;
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
|
[10]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-170; SER-174; SER-244 AND SER-415, AND MASS SPECTROMETRY.
DOI=10.1021/pr050048h; PubMed=16083285 [NCBI, ExPASy, EBI, Israel, Japan]
Kim J.-E.,
Tannenbaum S.R.,
White F.M.;
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
J. Proteome Res. 4:1339-1346(2005).
|
[11]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-574, AND MASS SPECTROMETRY.
DOI=10.1038/nbt1046; PubMed=15592455 [NCBI, ExPASy, EBI, Israel, Japan]
Rush J.,
Moritz A.,
Lee K.A.,
Guo A.,
Goss V.L.,
Spek E.J.,
Zhang H.,
Zha X.-M.,
Polakiewicz R.D.,
Comb M.J.;
"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
Nat. Biotechnol. 23:94-101(2005).
|
[12]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130; SER-170; SER-192; SER-244; SER-394; SER-398; SER-400; SER-440; SER-441; THR-445 AND SER-986, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.cell.2006.09.026; PubMed=17081983 [NCBI, ExPASy, EBI, Israel, Japan]
Olsen J.V.,
Blagoev B.,
Gnad F.,
Macek B.,
Kumar C.,
Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.";
Cell 127:635-648(2006).
|
[13]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1038/nbt1240; PubMed=16964243 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A.,
Villen J.,
Gerber S.A.,
Rush J.,
Gygi S.P.;
"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.";
Nat. Biotechnol. 24:1285-1292(2006).
|
[14]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1131, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0611217104; PubMed=17287340 [NCBI, ExPASy, EBI, Israel, Japan]
Molina H.,
Horn D.M.,
Tang N.,
Mathivanan S.,
Pandey A.;
"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.";
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
|
[15]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168; SER-170; SER-174; SER-244; SER-266; SER-415; SER-702; SER-966; SER-978; SER-986 AND SER-1159, AND MASS SPECTROMETRY.
TISSUE=Platelet;
DOI=10.1021/pr0704130; PubMed=18088087 [NCBI, ExPASy, EBI, Israel, Japan]
Zahedi R.P.,
Lewandrowski U.,
Wiesner J.,
Wortelkamp S.,
Moebius J.,
Schuetz C.,
Walter U.,
Gambaryan S.,
Sickmann A.;
"Phosphoproteome of resting human platelets.";
J. Proteome Res. 7:526-534(2008).
|
[16]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1159, AND MASS SPECTROMETRY.
TISSUE=Liver;
DOI=10.1002/pmic.200700884; PubMed=18318008 [NCBI, ExPASy, EBI, Israel, Japan]
Han G.,
Ye M.,
Zhou H.,
Jiang X.,
Feng S.,
Jiang X.,
Tian R.,
Wan D.,
Zou H.,
Gu J.;
"Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.";
Proteomics 8:1346-1361(2008).
|
[17]
|
VARIANT FHCA ALA-48.
DOI=10.1038/ng1147; PubMed=12704386 [NCBI, ExPASy, EBI, Israel, Japan]
Carlton V.E.H.,
Harris B.Z.,
Puffenberger E.G.,
Batta A.K.,
Knisely A.S.,
Robinson D.L.,
Strauss K.A.,
Shneider B.L.,
Lim W.A.,
Salen G.,
Morton D.H.,
Bull L.N.;
"Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT.";
Nat. Genet. 34:91-96(2003).
|
|